Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

The diseases include dengue, chikungunya, zika and yellow fever among others. India experiences a large number of deaths due ...

U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible ...

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

A total of 19,901 dengue cases have been reported in the country so far this year, according to the National Dengue Control ...

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk about the latest health news. Dr. Marty answers questions about the ...

Researchers say they've discovered an already approved migraine drug that can stop symptoms hours before a severe headache ...

Highlighting the pivotal role of VHSNCs in addressing public health concerns, the minister said that the committees would ...

Mosquitoes are highly visual hunters when it comes to finding a human to bite. This means movement and dark clothing colors ...